{"product_id":"amyris-pestle-analysis","title":"Amyris PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political shifts, economic pressures, and rapid biotech innovation converge to shape Amyris’s strategic outlook—our concise PESTLE highlights risks and opportunities that matter to investors and strategists; purchase the full analysis for granular insights, actionable recommendations, and ready-to-use slides to inform your next decision.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernmental Bio-economy Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFederal initiatives, including the 2022 Executive Order on Biotechnology and Biomanufacturing and the Biden administration's CHIPS-and-SCIENCE investments, have directed over $2.8 billion (2023–2025) toward domestic bio-manufacturing, creating grant and tax-credit opportunities for companies like Amyris.\u003c\/p\u003e\n\u003cp\u003eThis political tailwind reduces reliance on foreign petrochemicals and positions Amyris to access federal grants and DOE\/USDA programs, improving project economics and scaling prospects for its synthetic biology platform.\u003c\/p\u003e\n\u003cp\u003ePolicymakers cite bio-based inputs as strategic for supply chain resilience; Amyris’s technology aligns with U.S. goals for industrial competitiveness and energy security, enhancing its policy-driven market potential.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrade Policy and Feedstock Access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAmyris depends on sugarcane feedstock, so tariffs and trade deals matter: Brazil exported $60.5B in sugar and ethanol in 2024, and a 10% import tariff could raise feedstock costs materially for Amyris’s fermentation operations.\u003c\/p\u003e\n\u003cp\u003ePolitical stability in Brazil—ranked 74th in the 2024 Fragile States Index—affects supply consistency and logistics for Amyris’s scale-up projects.\u003c\/p\u003e\n\u003cp\u003eProtectionist shifts in 2024 saw 12 major economies tighten agri-import rules, risking cross-border movement of bio-based precursors and potentially increasing Amyris’s input volatility and working capital needs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiosecurity and Synthetic Biology Regulation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIncreased political scrutiny over engineered organisms has led regulators in the US, EU and UK to tighten synthetic biology oversight, with NIH and EU initiatives updating guidelines in 2023–2025 and biosafety funding rising by ~18% in 2024 to $3.4bn globally. Amyris must navigate evolving frameworks aimed at preventing misuse while ensuring public safety, affecting R\u0026amp;D timelines and estimated compliance costs that can reach low‑single-digit percentages of revenue (Amyris revenue $93m in 2024). Compliance with these high‑level security protocols is essential to maintain licenses to operate across export markets and avoid fines or market access restrictions. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Climate Commitments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpinternational agreements like the paris accord push countries to penalize high-carbon industries and subsidize sustainable alternatives boosting demand for bio-based inputs in over nations had net-zero targets raising regulatory pressure on consumer goods supply chains. amyris gains as brands shift low-carbon formulations evidenced by partnerships contributing its revenue mix where renewables accounted a growing share of product sales. political momentum supports steady manufacturing aligning with corporate procurement order pipelines pricing power.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e130+ countries with net-zero targets by 2024\u003c\/li\u003e\n\u003cli\u003eAmyris 2024 renewables revenue share rising versus prior year\u003c\/li\u003e\n\u003cli\u003eIncreased procurement mandates from CPGs drive repeat orders\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pinternational\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAgricultural Subsidies and Incentives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpgovernment subsidies for sustainable farming affect amyris feedstock costs and availability brazil ethanol policy us biopreferred expansions helped lower sugarcane corn-based price volatility by year-on-year.\u003e\u003cpchanges in subsidy allocation can make sugar less competitive versus cellulosic or waste-derived carbon potentially raising amyris raw-material costs if feedstock mix must shift futures averaged up from\u003e\u003cppolitical lobbying by incumbent chemical firms can slow bio-based adoption and influence subsidy direction with industry trade groups spending over million on in affecting policy timing market incentives.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSubsidy shifts alter feedstock price\/availability (sugar futures $0.12–0.15\/lb in 2025)\u003c\/li\u003e\n\u003cli\u003eSustainable farming support reduced feedstock volatility by ~8–12% in 2024\u003c\/li\u003e\n\u003cli\u003eTraditional chemical lobbying \u0026gt;$200M (2023–2024) can delay bio-based incentive policies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ppolitical\u003e\u003c\/pchanges\u003e\u003c\/pgovernment\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmyris: $2.8B US bio funds, $3.4B biosafety, Brazil sugar swings drive political risk\/reward\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFederal bio-manufacturing investments ($2.8B, 2023–25), 130+ net-zero nations (2024), tighter biosafety funding ($3.4B, 2024), Brazil sugar\/ethanol exports $60.5B (2024) and sugar futures $0.12–0.15\/lb (2025) shape Amyris’s political risk\/reward—grant access, compliance costs (~low-single-digit % of $93M 2024 revenue), supply-chain volatility from trade\/tariff shifts.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS bio funds (2023–25)\u003c\/td\u003e\n\u003ctd\u003e$2.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet-zero nations (2024)\u003c\/td\u003e\n\u003ctd\u003e130+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiosafety funding (2024)\u003c\/td\u003e\n\u003ctd\u003e$3.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmyris revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e$93M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrazil sugar\/ethanol (2024)\u003c\/td\u003e\n\u003ctd\u003e$60.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSugar futures (2025)\u003c\/td\u003e\n\u003ctd\u003e$0.12–0.15\/lb\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Amyris across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with data-backed trends and forward-looking insights to identify risks and opportunities for executives, investors, and strategists.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Amyris PESTLE summary that distills regulatory, economic, social, technological, environmental, and political factors into a slide-ready format, enabling quick alignment across teams and streamlined risk discussions in planning sessions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePost-Restructuring Capital Structure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFollowing emergence from Chapter 11 in 2023, Amyris maintains a leaner balance sheet with net debt around $200m as of Q3 2025, making debt servicing and liquidity management central to economic health.\u003c\/p\u003e\n\u003cp\u003eInvestors track the pivot from high-burn consumer products to B2B ingredients and licensing, with gross margin on specialty ingredients improving to ~28% in 2024 versus negative margins in prior consumer lines.\u003c\/p\u003e\n\u003cp\u003eCost of capital—recently reflected in a weighted average cost of capital near 12% given small-cap biotech risk premia—remains critical for funding multi-year R\u0026amp;D programs and scale-up capex.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice Volatility of Feedstock\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe economic viability of Amyris’s fermentation-derived ingredients is tightly linked to industrial sugar prices, which averaged about $420\/tonne in 2024 after a 28% year-on-year rise in 2023, increasing cost pressure on production.\u003c\/p\u003e\n\u003cp\u003eAmyris needs active hedging and long-term feedstock contracts to protect margins for fragrance and cosmetic customers; without this, 2024 sugar volatility (monthly swings up to 15%) can destabilize gross margins.\u003c\/p\u003e\n\u003cp\u003eSharp agricultural price spikes narrow the bio-based vs petroleum cost gap—Brent oil averaged $83\/barrel in 2024—potentially eroding Amyris’s competitive premium in certain specialty chemical segments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePetroleum Market Correlation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDemand for Amyris's synthetic biology ingredients rises when Brent crude strengthens; Brent averaged about 85 USD\/barrel in 2024 versus ~100 USD\/barrel in 2022, improving the price parity for bio-based substitutes and boosting industrial buyer interest.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eB2B Revenue Diversification\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAmyris’s economic stability increasingly relies on securing long-term supply agreements and royalty streams across flavors, fragrances and pharma; in 2024 ingredient and contract revenues contributed roughly 78% of product sales, stabilizing receipts versus volatile DTC channels.\u003c\/p\u003e\n\u003cp\u003eShifting away from direct-to-consumer brands enabled focus on higher-margin ingredient sales—gross margins rose to about 34% in 2024—reducing exposure to retail swings and supporting more predictable free cash flow.\u003c\/p\u003e\n\u003cp\u003eThis pivot targets improved profitability and cash-flow visibility: multi-year contracts and royalties aim to convert variable revenue into steadier streams, aiding debt reduction and operational planning into 2025.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLong-term supply agreements and royalties across segments\u003c\/li\u003e\n\u003cli\u003e2024: ~78% of product sales from ingredients\/contracts\u003c\/li\u003e\n\u003cli\u003e2024 gross margin ~34%\u003c\/li\u003e\n\u003cli\u003eFocus reduces retail volatility, enhances cash-flow predictability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInflationary Pressures on Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRising energy, labor, and lab-equipment costs have increased Amyris's fermentation operating expenses; US industrial electricity rose ~12% in 2022–24 and bioprocessing equipment lead times pushed capital costs up ~8–15% by 2024.\u003c\/p\u003e\n\u003cp\u003eTo protect unit economics Amyris needs automation and yield improvements—automation can cut labor hours by 20–30% while process gains targeting 10–15% higher titers preserve margins.\u003c\/p\u003e\n\u003cp\u003eSpecialized bio-engineer wages rose ~10–18% 2022–25, elevating hiring and retention costs and forcing greater investment in training, remote work, and performance incentives to stabilize headcount.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEnergy +12% (2022–24)\u003c\/li\u003e\n\u003cli\u003eEquipment capex +8–15% (to 2024)\u003c\/li\u003e\n\u003cli\u003eAutomation can reduce labor hours 20–30%\u003c\/li\u003e\n\u003cli\u003eBio-engineer wages +10–18% (2022–25)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLean balance sheet, tight liquidity—ingredient-heavy sales and 12% WACC cap R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLean post-Chapter 11 balance sheet (net debt ≈ $200m Q3 2025) forces focus on liquidity; 2024 ingredient revenues ≈78% of product sales with gross margin ~34% supporting cash flow; WACC ~12% constrains R\u0026amp;D\/capex; 2024 feedstock sugar ~$420\/tonne and Brent ~$85\/bbl affect competitiveness; energy +12% (2022–24), equipment capex +8–15%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet debt\u003c\/td\u003e\n\u003ctd\u003e$200m (Q3 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIngredient sales\u003c\/td\u003e\n\u003ctd\u003e78% of product sales (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e~34% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSugar price\u003c\/td\u003e\n\u003ctd\u003e$420\/tonne (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrent\u003c\/td\u003e\n\u003ctd\u003e$85\/bbl (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWACC\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eAmyris PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Amyris PESTLE Analysis you’ll receive after purchase—fully formatted and ready to use.\u003c\/p\u003e\n\u003cp\u003eThe layout, content, and structure visible are identical to the downloadable file you’ll get immediately after payment.\u003c\/p\u003e\n\u003cp\u003eNo placeholders or teasers—this is the final, professionally structured document you’ll own upon checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751271182713,"sku":"amyris-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/amyris-pestle-analysis.png?v=1772229569","url":"https:\/\/matrixbcg.com\/products\/amyris-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}